Nippon Chemiphar Co., Ltd. (TYO:4539)

Japan flag Japan · Delayed Price · Currency is JPY
1,768.00
+18.00 (1.03%)
Feb 13, 2026, 3:30 PM JST
Market Cap6.38B +18.3%
Revenue (ttm)32.52B +1.7%
Net Income545.00M
EPS150.99
Shares Out3.61M
PE Ratio11.71
Forward PEn/a
Dividend50.00 (2.86%)
Ex-Dividend DateMar 30, 2026
Volume2,600
Average Volume3,590
Open1,756.00
Previous Close1,750.00
Day's Range1,748.00 - 1,768.00
52-Week Range1,410.00 - 1,768.00
Beta0.23
RSI77.61
Earnings DateJan 30, 2026

About Nippon Chemiphar

Nippon Chemiphar Co., Ltd., together with its subsidiaries, engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally. the company offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. It also develops NC-2400, a PPAR-delta agonist currently under phase 1 development; NC-2500, a XOR inhibitor for the treatment o... [Read more]

Sector Healthcare
Founded 1950
Employees 855
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4539
Full Company Profile

Financial Performance

Financial Statements